Key result
Second BNT162b2 dose linked to acute myopericarditis mimicking ACS.
Why the study?
Myocarditis is a rare adverse event of mRNA COVID-19 vaccination, with limited data on cases mimicking acute coronary syndrome in middle-aged patients.
Case Report (n=1)
Alerts clinicians to myopericarditis in middle-aged adults with post-vaccination chest pain; extends demographics but remains hypothesis-generating.
Myocarditis is a rare adverse event of vaccination. Recently, mRNA vaccines for COVID-19 have been reported to correlate with myocarditis, specifically in adolescents and young men. We report a rare case of a 50-year-old man who presented with symptoms of myocardial infarction 3 days after the second dose of vaccination for COVID-19. Cardiac magnetic resonance (CMR) imaging revealed acute myopericarditis. Clinicians should be aware of that rare side effect of mRNA vaccines for COVID-19 that can affect not only younger recipients but also middle-aged patients presenting with symptoms mimicking acute coronary syndrome.
No takes yet. Share an insight, caveat, or question.
Pantsios et al. (2022) conducted a case report in Acute myopericarditis (n=1). BNT162b2 mRNA COVID-19 vaccine was evaluated on Diagnosis of acute myopericarditis. A 50-year-old man developed acute myopericarditis mimicking acute coronary syndrome three days after receiving his second dose of the BNT162b2 mRNA COVID-19 vaccine.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: